YHLO





NEWS：

凯发体育官网-凯发平台app-凯发网娱乐下载 showcased at 13th International Congress on Autoimmunity

 2022-06-22

Global registration overview of 凯发体育官网-凯发平台app-凯发网娱乐下载 diagnostic kits for Novel Coronavirus COVID-19 Antigen/Antibody

 2022-06-22

Meet 凯发体育官网-凯发平台app-凯发网娱乐下载 at 13th International Autoimmunity Congress in Greece

 2022-05-31

Officially Established, 凯发体育官网-凯发平台app-凯发网娱乐下载 Japan R&D Center Set sail

 2022-04-02

Added To 600,000 Tests, 凯发体育官网-凯发平台app-凯发网娱乐下载 And C-Mer Donated COVID-19 Antigen Tests To Hong Kong Again

 2022-02-25





About 凯发体育官网-凯发平台app-凯发网娱乐下载

凯发体育官网-凯发平台app-凯发网娱乐下载 (EST. 2008) is an innovative and steadfastly growing company of immunoassay solutions headquartered in Shenzhen, China, specialized in developing, manufacturing and distributing in-vitro diagnostic instruments and reagents by a team of experienced scientists and engineers. In May of 2021, 凯发体育官网-凯发平台app-凯发网娱乐下载 has successfully launched IPO and listed on Shanghai Stock Exchange (Stock code: 688575). As a national high-tech enterprise with many intellectual properties, 凯发体育官网-凯发平台app-凯发网娱乐下载’s mission is to "Focus on Healthcare, Better Life with Technology".

Diagnostic for Human Health

Milestone

Corporate Values

Contact Us

MORE+

Home

About 凯发体育官网-凯发平台app-凯发网娱乐下载

Products

Services

News

Company Profile Milestone Corporate Values

About 凯发体育官网-凯发平台app-凯发网娱乐下载

More +

Clinical Solution CLIA ELISA LIA POCT ESR COVID-19

Products

Based on the technology platforms of CLIA, ELISA, LIA and immunofluorescence, 凯发体育官网-凯发平台app-凯发网娱乐下载 is specialized in diagnosis of autoimmunity, reproductive health, diabetes, infectious diseases etc.

More +